Skip to main content

Closed

BFRI: Biofrontera Inc. Stock Analysis | finqOS

Healthcare · Medical - Pharmaceuticals

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+11.8% / yr

Operating margin-20.6%

ROIC-62.1%

Financially safe

Stretched

Debt / equity1.27×

Interest coverage-40.4×

Current ratio1.20×

Biofrontera Inc.

BFRINASDAQ·USD·Closed

Biofrontera Inc.

BFRINASDAQ·USD·Closed

$1.17

−4.88%

$1.17

−$0.06 (4.88%)

52W Range

86thpctl

Volume

1.41×avg

Mkt Cap

14.98MUSD

P/E

-1.1TTM

Div Yield

–ann

52W Range

86thpctl

Volume

1.41×avg

Market Cap

14.98MUSD

P/E Ratio

-1.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings